Sign up to save your podcasts
Or
Share Residual tumor volume and survival after CCNU/TMZ in GBM
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Residual tumor volume and survival after CCNU/TMZ in GBM
Dr. Iyad Alnahhas interviews Drs. Thomas Zeyen and Johannes Weller about their recent manuscript entitled: "Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with CCNU/TMZ", published online in Neuro-Oncology in October 2024.
View all episodes
By Neuro-Oncology
4.8
1212 ratings
Dr. Iyad Alnahhas interviews Drs. Thomas Zeyen and Johannes Weller about their recent manuscript entitled: "Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with CCNU/TMZ", published online in Neuro-Oncology in October 2024.
More shows like Neuro-Oncology: The Podcast
View all
Planet Money
30,687 Listeners
Hidden Brain
43,741 Listeners
Global News Podcast
7,707 Listeners
The Gray Area with Sean Illing
10,749 Listeners
NEJM This Week
318 Listeners
Mayo Clinic Talks
291 Listeners
The Curbsiders Internal Medicine Podcast
3,349 Listeners
The Daily
112,946 Listeners
Up First from NPR
56,549 Listeners
Today, Explained
10,293 Listeners
The Peter Attia Drive
9,202 Listeners
Hard Fork
5,477 Listeners
The Ezra Klein Show
16,095 Listeners
New Heights with Jason & Travis Kelce
18,033 Listeners
Not Gonna Lie with Kylie Kelce
10,254 Listeners